Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunovant (IMVT) Cash from Investing Activities (2019 - 2026)

Immunovant filings provide 7 years of Cash from Investing Activities readings, the most recent being -$201000.0 for Q1 2025.

  • Quarterly Cash from Investing Activities fell 34.0% to -$201000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$201000.0 through Dec 2025, up 71.61% year-over-year, with the annual reading at -$759000.0 for FY2025, 110.83% down from the prior year.
  • Cash from Investing Activities hit -$201000.0 in Q1 2025 for Immunovant, down from -$180000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$18000.0 in Q2 2021 and bottomed at -$201000.0 in Q1 2025.
  • Average Cash from Investing Activities over 5 years is -$97941.2, with a median of -$95000.0 recorded in 2021.
  • The largest annual shift saw Cash from Investing Activities crashed 850.0% in 2021 before it surged 77.97% in 2023.
  • Immunovant's Cash from Investing Activities stood at -$74000.0 in 2021, then plummeted by 32.43% to -$98000.0 in 2022, then plummeted by 33.67% to -$131000.0 in 2023, then tumbled by 37.4% to -$180000.0 in 2024, then dropped by 11.67% to -$201000.0 in 2025.
  • Per Business Quant, the three most recent readings for IMVT's Cash from Investing Activities are -$201000.0 (Q1 2025), -$180000.0 (Q4 2024), and -$196000.0 (Q3 2024).